Elizabeth Tanner

At Scientist, we discuss the latest trends in drug development, techniques, and the pharmaceutical industry. Here are the top posts from 2013. 10...

The need for CNS therapeutics is on the rise. Neurological diseases are expected to increase steadily in the coming years. Previously, we addressed...

More than $2 trillion dollars a year are spent on treatments for CNS disorders. One in three people over 80 currently has Alzheimer’s disease. With...

The BRAIN Initiative sponsored by the NIH has pushed neuroscience and technology to center stage with President Obama supporting advancing...

Is there a way to quantify early drug discovery productivity to improve pharmaceutical innovation? Pharmaceutical innovation is dependent upon a...

Stem cells are being used to develop robust, reliable disease models that are advancing our understanding of underlying disease progression and...

How are stem cells advancing compound screening and analysis of drug-like properties? Stem cells are emerging as significant reagents in drug...

Advances in Culturing Stem Cells Stem cells may hold the answer to one of the biggest medical challenges, replacing tissues and organs. Exciting...

Development of clinical diagnostics is a major target for pharmaceutical companies. Drug development is facing new challenges as it becomes more...